Dhanpat Jain, MD, Appointed to Cancer Committee of College of American Pathologists
Dhanpat Jain, MD, Professor of Pathology and of Medicine (Digestive Diseases), has been named to the Cancer Committee of the College of American Pathologists (CAP), the leading organization of board-certified pathologists that fosters and advocates excellence in the practice of pathology and laboratory medicine worldwide.
What Is Liver Cancer? Symptoms, Causes, Diagnosis, Treatment, and Prevention
Liver cancer starts in the cells of the liver — a vital internal organ that performs many important functions, including storing nutrients that the body uses for energy, removing harmful chemicals and other substances from the blood, and making bile to help the body digest fat from food.Source: Everyday Health
Association of Pathology Chairs Names Chen Liu, MD, PhD, to 2nd Term as Chair of Practice & Management Committee
Chen Liu, MD, PhD, Chair of the Department of Pathology at Yale School of Medicine, has been elected to his second term as Chair of the Practice & Management Committee of the Association of Pathology Chairs (APC).
Surgical Oncology Expertise Available at Smilow Cancer Hospital Care Center in Trumbull
Smilow Cancer Hospital surgical oncologists are available to provide advanced care and superb clinical outcomes for patients with liver, pancreas, biliary, upper gastrointestinal, and peritoneal surface cancers, in addition to melanoma and sarcoma.
Sanja Dacic, MD, PhD, Appointed Vice Chair and Director of Anatomic Pathology at Yale Pathology
Sanja Dacic, MD, PhD, an internationally renowned and highly accomplished leader in anatomic pathology, has been appointed Vice Chair and Director of Anatomic Pathology in the Department of Pathology at Yale School of Medicine, effective May 1, 2022.
Here Are the Top Signs of Liver Cancer—Plus Everything You Need to Know About Screening and Treatment
The liver is one of the hardest-working organs in your body and has many life-sustaining functions. And, health experts say everyone should care about liver health, especially as cases of liver cancer have been on the rise in the U.S. over the past few decades.Source: Parade
Adapting to the Changing Liver Cancer Landscape
In recent years, the liver cancer landscape has been rapidly changing in the United States. Skyrocketing hepatitis C cases and the emergence of a worrying new at-risk group for hepatitis C are presenting Yale Cancer Center researchers and clinicians with new challenges and opportunities in their approach to patient outreach and treatment for liver cancer.
Standardizing Evaluation after Liver Cancer Treatment could Save US Healthcare More than $575M per Year
Standardizing imaging evaluation after treating the most common type of liver cancer could save the U.S. healthcare system more than $575 million, according to a new study in JACR.Source: Radiology Business
Radiombolization paper publication a “landmark moment” for IR-Hepatology collaboration
The cover of June’s edition of the Journal of Hepatology featured a paper on transarterial radioembolization for the treatment of hepatocellular carcinoma (HCC). Publication of the paper, authored by Riad Salem (Department of Radiology, Northwestern University, Chicago, USA) and colleagues, has been described as a “milestone” for interventional radiology (IR) as a specialty and has heralded a call for greater collaboration between interventional radiologists and their Hepatology colleagues.Source: Interventional News